Dr. Wolfe is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 State Street
Boston, MA 02109
Summary
- Dr. David Wolfe is Chief Medical Officer of MBHP and Manager Medical Director at Carelon Behavioral Health. Dr. Wolfe joined MBHP from Mass General Brigham Newton-Wellesley Hospital, where he had served as Chair, Department of Psychiatry until 2021. Since 2007, he has worked as an attending psychiatrist at Brigham and Women's Hospital (BWH), where he held the roles of Associate Vice Chair for Clinical Services; Chief, Division of Ambulatory Services; Director, Transcranial Magnetic Stimulation Services, and Director of Psychiatric Education and Training. Dr. Wolfe completed his residency in the Harvard-Longwood Psychiatric Residency Training Program and a fellowship in psychosomatic medicine at BWH. He is a graduate of Tufts University School of Medicine (MD and MPH) and the University of Massachusetts Isenberg School of Management (MBA). He has more than 10 publications and over 100 citations. He holds a faculty appointment at Harvard Medical School.
Education & Training
- University of Massachusetts AmherstMBA, 2020 - 2022
- Brigham and Women's HospitalFellowship, Consultation-Liaison Psychiatry, 2006 - 2007
- Brigham and Women's Hospital/Harvard Medical SchoolResidency, Psychiatry, 2002 - 2006
- Tufts University School of MedicineClass of 2002
Certifications & Licensure
- MA State Medical License 2004 - 2025
- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Riluzole Augmentation Pilot in Depression (RAPID) Trial Start of enrollment: 2013 Jan 01
Publications & Presentations
PubMed
- 15 citationsWorking memory in schizotypal personality disorder: fMRI activation and deactivation differencesMai-Anh T. Vu, Heidi W. Thermenos, Douglas P. Terry, David J. Wolfe, Martina M. Voglmaier
Schizophrenia Research. 2013-12-01 - 14 citationsAre short (blue) wavelengths necessary for light treatment of seasonal affective disorderJanis L. Anderson, M. A. St. Hilaire, R. Robert Auger, Carol A. Glod, Scott J. Crow
Chronobiology International. 2016-08-05 - 33 citationsAntipsychotic prophylaxis in surgical patients modestly decreases delirium incidence — but not duration — in high-incidence samples: A meta-analysisMarsha L. Gilmore, David J. Wolfe
General Hospital Psychiatry. 2013-07-01
Press Mentions
- Study: Ketamine Acts like an Opioid When Used to Help Treat DepressionAugust 31st, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: